UK/Czech scientists shed light on insulin activity
An Anglo-Czech team of scientists has discovered how insulin interacts with cells in the human body. Published in the journal Proceedings of the National Academy of Science (PNAS), the findings could give a major boost to researchers hoping to develop viable treatments to fight type I diabetes.
People need insulin, a key protein hormone regulating blood sugar levels that impacts lipid and protein metabolism. Insulin is particularly important in the treatment of diabetes, a disorder that affects some 25 million people in Europe. Based on data from the International Diabetes Federation (IDF), the number of Europeans with diabetes will increase to 29 million in 2025.
Particular problem in sub-Saharan Africa
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze